Zobrazeno 1 - 10
of 846
pro vyhledávání: '"Ms, Berger"'
Autor:
BD Smith, CB Leary, MD Kaufman, MM Hood, W-P Lu, BA Turner, S Vogeti, SC Wise, MS Berger, DL Flynn
Publikováno v:
Cancer Research. 73:P4-15
In cancer models, TIE2 kinase plays an important role in angiogenesis, vasculogenesis, and tumor metastasis. TIE2 expression is largely restricted to vascular endothelial cells, tissue macrophages, and bone marrow derived TIE2-expressing monocytes (T
Publikováno v:
Europe PubMed Central
Human malignant gliomas are thought to develop as the result of stepwise accumulations of multiple genetic alterations. Recently, we showed that E6/E7-mediated inactivation of p53/pRb, ras pathway activation (initiated by expression of mutant H-Ras),
Publikováno v:
Europe PubMed Central
The formation of human malignant gliomas is thought to involve the accumulation of multiple genetic alterations. To define the function of specific alterations in glioma formation, we serially introduced genetic alterations functionally equivalent to
Autor:
Sm, Chang, Jg, Kuhn, Rizzo J, Hi, Robins, Sc, Schold, Am, Spence, Ms, Berger, minesh mehta, Me, Bozik, Pollack I, Gilbert M, Fulton D, Rankin C, Malec M, Md, Prados
Publikováno v:
Scopus-Elsevier
Europe PubMed Central
Europe PubMed Central
PURPOSE To determine the maximum-tolerated dose (MTD) of paclitaxel administered as a 3-hour infusion in patients with recurrent malignant glioma. PATIENTS AND METHODS Patients were stratified by starting dose of paclitaxel and concurrent anticonvuls
Autor:
Hirsch Ballin, E., Cleiren, T., Karin Arts, Ms, Berger, Donders, Y., Gerards, J., Hamburger, A., Heerts, T., Hoeven, R., Jägers, N., Lawson, R., Monteiro, M., Myjer, E., Opschoor, H., Schermer, B., Tahir, N., Verrijn Stuart, H.
Publikováno v:
EUR Research Portal
See https://aiv-advies.nl/b08
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::ae042aad0ae9a5cafb9bf9e417f3f002
https://pure.eur.nl/en/publications/478b7410-107a-46c8-ab22-20b98bcca712
https://pure.eur.nl/en/publications/478b7410-107a-46c8-ab22-20b98bcca712
Publikováno v:
Publons
Temozolomide (TMZ) produces O(6)-methylguanine in DNA, which in turn mispairs with thymine, triggering futile DNA mismatch repair (MMR) and ultimately cell death. We found previously that in p53-proficient human glioma cells, TMZ-induced futile DNA M
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::86dff2512b26dbbf6a4d23261c9f4c73
https://publons.com/publon/19878763/
https://publons.com/publon/19878763/
Autor:
Sm, Chang, Jg, Kuhn, Hi, Robins, Sc, Schold, Am, Spence, Ms, Berger, minesh mehta, Me, Bozik, Pollack I, Schiff D, Gilbert M, Rankin C, Md, Prados
Publikováno v:
Europe PubMed Central
PURPOSE: To determine the response rate, time to treatment failure, and toxicity of phenylacetate in patients with recurrent malignant glioma and to identify plasma concentrations achieved during repeated continuous infusion of this agent. PATIENTS A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a5dfb914c185a767e954614472541b7
http://europepmc.org/abstract/med/10071293
http://europepmc.org/abstract/med/10071293
Autor:
Liu SJ; Department of Radiation Oncology, University of California San Francisco, San Francisco, CA, 94143, USA.; Department of Neurological Surgery, University of California San Francisco, San Francisco, CA, 94143, USA.; Arc Institute, Palo Alto, CA, 94304, USA., Zou C; Department of Radiation Oncology, University of California San Francisco, San Francisco, CA, 94143, USA.; Department of Neurological Surgery, University of California San Francisco, San Francisco, CA, 94143, USA., Pak J; Department of Radiation Oncology, University of California San Francisco, San Francisco, CA, 94143, USA.; Department of Neurological Surgery, University of California San Francisco, San Francisco, CA, 94143, USA., Morse A; Department of Anatomy, University of California San Francisco, San Francisco, CA, 94143, USA., Pang D; Department of Anatomy, University of California San Francisco, San Francisco, CA, 94143, USA., Casey-Clyde T; Department of Radiation Oncology, University of California San Francisco, San Francisco, CA, 94143, USA.; Department of Neurological Surgery, University of California San Francisco, San Francisco, CA, 94143, USA.; Department of Pathology, University of California San Francisco, San Francisco, CA, 94143, USA., Borah AA; Arc Institute, Palo Alto, CA, 94304, USA.; Biological and Medical Informatics Graduate Program, University of California San Francisco, San Francisco, CA, 94143, USA., Wu D; Department of Neurological Surgery, University of California San Francisco, San Francisco, CA, 94143, USA., Seo K; Department of Radiation Oncology, University of California San Francisco, San Francisco, CA, 94143, USA.; Department of Neurological Surgery, University of California San Francisco, San Francisco, CA, 94143, USA.; Department of Pathology, University of California San Francisco, San Francisco, CA, 94143, USA., O'Loughlin T; Department of Neuroscience, Icahn School of Medicine, Mount Sinai, New York, NY, 10029, USA., Lim DA; Department of Neurological Surgery, University of California San Francisco, San Francisco, CA, 94143, USA., Ozawa T; Department of Neurological Surgery, University of California San Francisco, San Francisco, CA, 94143, USA., Berger MS; Department of Neurological Surgery, University of California San Francisco, San Francisco, CA, 94143, USA., Kamber RA; Department of Anatomy, University of California San Francisco, San Francisco, CA, 94143, USA., Weiss WA; Department of Neurological Surgery, University of California San Francisco, San Francisco, CA, 94143, USA.; Departments of Pediatrics, Neurology, and Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, 94143, USA., Raleigh DR; Department of Radiation Oncology, University of California San Francisco, San Francisco, CA, 94143, USA. david.raleigh@ucsf.edu.; Department of Neurological Surgery, University of California San Francisco, San Francisco, CA, 94143, USA. david.raleigh@ucsf.edu.; Department of Pathology, University of California San Francisco, San Francisco, CA, 94143, USA. david.raleigh@ucsf.edu., Gilbert LA; Arc Institute, Palo Alto, CA, 94304, USA. luke@arcinstitute.org.; Department of Urology, University of California San Francisco, San Francisco, CA, 94143, USA. luke@arcinstitute.org.
Publikováno v:
Genome biology [Genome Biol] 2024 Oct 07; Vol. 25 (1), pp. 256. Date of Electronic Publication: 2024 Oct 07.
Autor:
Hotchkiss KM; The Preston Robert Tisch Brain Tumor Center at Duke, Department of Neurosurgery, Duke University Medical Center, Durham, NC, USA., Karschnia P; Department of Neurosurgery, Friedrich-Alexander University, Erlangen, Germany; Ludwig-Maximilians-University, Munich, Germany; German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany., Schreck KC; Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Geurts M; Department of Neurology, Erasmus MC Cancer Center, Rotterdam, Netherlands; Department of Medical Oncology, Erasmus MC Cancer Center, Rotterdam, Netherlands., Cloughesy TF; David Geffen School of Medicine at UCLA, Los Angeles, CA, USA., Huse J; Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Duke ES; Division of Oncology 2, Office of Oncologic Diseases, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA., Lathia J; Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA; Rose Ella Burkhardt Brain Tumor and Neuro-Oncology Center, Cleveland Clinic, Cleveland, OH, USA; Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, OH, USA., Ashley DM; The Preston Robert Tisch Brain Tumor Center at Duke, Department of Neurosurgery, Duke University Medical Center, Durham, NC, USA., Nduom EK; Department of Neurosurgery, Emory University School of Medicine, Atlanta, GA, USA., Long G; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia; Faculty of Medicine and Health, Charles Perkins Centre, The University of Sydney, Sydney, NSW, Australia; Mater and Royal North Shore Hospitals, Sydney, NSW, Australia., Singh K; The Preston Robert Tisch Brain Tumor Center at Duke, Department of Neurosurgery, Duke University Medical Center, Durham, NC, USA., Chalmers A; School of Cancer Sciences, University of Glasgow, Glasgow, UK., Ahluwalia MS; Baptist Health South Florida, Miami, FL, USA., Heimberger A; Department of Neurological Surgery, Northwestern University, Chicago, IL, USA., Bagley S; University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA., Todo T; Department of Surgical Neuro-Oncology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan., Verhaak R; Department of Surgical Neuro-Oncology, Yale University, New Haven, CT, USA., Kelly PD; Department of Neurosurgery, Vanderbilt University Medical Center, Nashville, TN, USA., Hervey-Jumper S; Department of Neurological Surgery, UCSF Brain Tumor Center, University of California San Francisco, San Francisco, CA, USA; Weill Institute for Neuroscience, Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA., de Groot J; Department of Neurological Surgery, UCSF Brain Tumor Center, University of California San Francisco, San Francisco, CA, USA; Weill Institute for Neuroscience, Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA., Patel A; The Preston Robert Tisch Brain Tumor Center at Duke, Department of Neurosurgery, Duke University Medical Center, Durham, NC, USA., Fecci P; The Preston Robert Tisch Brain Tumor Center at Duke, Department of Neurosurgery, Duke University Medical Center, Durham, NC, USA., Parney I; Department of Neurological Surgery, Mayo Clinic, Rochester, MN, USA., Wykes V; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK; Department of Neurosurgery, Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK., Watts C; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK; Department of Neurosurgery, Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK., Burns TC; Department of Neurological Surgery, Mayo Clinic, Rochester, MN, USA., Sanai N; Barrow Neurological Institute, Phoenix, AZ, USA., Preusser M; Department of Medicine I, Division of Oncology, Medical University of Vienna, Vienna, Austria., Tonn JC; Ludwig-Maximilians-University, Munich, Germany; German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany., Drummond KJ; Department of Neurosurgery, Royal Melbourne Hospital, Parkville, VIC, Australia; Department of Surgery, University of Melbourne, Parkville, VIC, Australia., Platten M; Department of Neurology, Mannheim Center for Translational Neuroscience, Medical Faculty Mannheim, Heidelberg University, Heidelberg, Germany; Clinical Cooperation Unit Brain Tumor Immunology (D170), German Cancer Research Center (DKFZ), Heidelberg, Germany., Das S; Division of Neurosurgery, University of Toronto, Toronto, ON, Canada., Tanner K; National Brain Tumor Society, Newton, MA, USA., Vogelbaum MA; H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Weller M; Department of Neurological Surgery, Mayo Clinic, Rochester, MN, USA; Department of Neurology, University Hospital Zurich, Zurich, Switzerland., Whittle JR; Department of Medical Biology, University of Melbourne, Parkville, VIC, Australia; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia; Personalised Oncology Division, Walter and Eliza Hall Institute, Parkville, VIC, Australia., Berger MS; Department of Neurological Surgery, UCSF Brain Tumor Center, University of California San Francisco, San Francisco, CA, USA; Weill Institute for Neuroscience, Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA., Khasraw M; The Preston Robert Tisch Brain Tumor Center at Duke, Department of Neurosurgery, Duke University Medical Center, Durham, NC, USA. Electronic address: mustafa.khasraw@duke.edu.
Publikováno v:
The Lancet. Oncology [Lancet Oncol] 2024 Oct; Vol. 25 (10), pp. e512-e519.
Autor:
Marino S; Neurosurgery Unit, Department of Neurosciences, Catholic University School of Medicine, Rome, Italy., Menna G; Neurosurgery Unit, Department of Neurosciences, Catholic University School of Medicine, Rome, Italy., Bilgin L; Neurosurgery Unit, Department of Neurosciences, Catholic University School of Medicine, Rome, Italy., Mattogno PP; Neurosurgery Unit, Department of Neurosciences, Fondazione Policlinico Universitario Agostino Gemelli, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Roma, Italy., Gaudino S; Diagnostic Neuroradiology Unit, Department of Radiological and Hematological Sciences, Fondazione Policlinico Universitario Agostino Gemelli, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Rome, Italy., Quaranta D; Neurology Unit, Neurorehabilitation and Neuropsychology Service, Fondazione Policlinico Universitario 'A. Gemelli', Istituto di Ricovero e Cura a Carattere Scientifico, San Giovanni Rotondo, Italy., Caraglia N; Neurology Unit, Neurorehabilitation and Neuropsychology Service, Fondazione Policlinico Universitario 'A. Gemelli', Istituto di Ricovero e Cura a Carattere Scientifico, San Giovanni Rotondo, Italy., Olivi A; Neurosurgery Unit, Department of Neurosciences, Catholic University School of Medicine, Rome, Italy; Neurosurgery Unit, Department of Neurosciences, Fondazione Policlinico Universitario Agostino Gemelli, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Roma, Italy., Berger MS; Department of Neurological Surgery, University of California, San Francisco, California, USA., Doglietto F; Neurosurgery Unit, Department of Neurosciences, Catholic University School of Medicine, Rome, Italy; Neurosurgery Unit, Department of Neurosciences, Fondazione Policlinico Universitario Agostino Gemelli, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Roma, Italy., Della Pepa GM; Neurosurgery Unit, Department of Neurosciences, Catholic University School of Medicine, Rome, Italy; Neurosurgery Unit, Department of Neurosciences, Fondazione Policlinico Universitario Agostino Gemelli, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Roma, Italy. Electronic address: mennagrazia@gmail.com.
Publikováno v:
World neurosurgery [World Neurosurg] 2024 Oct; Vol. 190, pp. 350-361.e20. Date of Electronic Publication: 2024 Jul 03.